About the Book:
·
Clarke’s Analysis of Drug and Poisons is the definitive source
of analytical data for drugs and poisons. This reference work has been
completely revised and updated for the new edition and comprises two volumes.
Volume 1 has been greatly
expanded from 31 to 44 chapters providing extensive coverage of all methodology
and analytical techniques. Of significant interest include:
1. Quality control and
assessment - separated into two chapters to reflect the differing
situations/purposes/remits of the toxicology laboratory versus the
pharmaceutical industry (accreditation with ISO17025 becoming the international
standard in labs)
2. Method development
and validation - now present since reliable analytical techniques and data
should be of the utmost importance to any analyst
3. 'Sampling, storage
and stability', 'Measuring and reporting uncertainty' and 'Interpretation of
results' now included to cover all aspects accreditation
4. Pharmacokinetics
now coupled with Pharmacogenomics
Volume 2 now contains:
1.
Over 2100 monographs detailing physical properties,
analytical methods, pharmacokinetic data, ultraviolet, infrared and mass
spectra, and therapeutic and toxicity data of drugs and poisons
2.
More than 350 new monographs
3.
Expanded indexes and appendices include CAS numbers,
empirical and molecular formulae, TLC, GC and HPLC systems data, as well as
therapeutic class.
This
book is essential for all forensic and clinical toxicologists, pathologists,
hospital pharmacists, pharmaceutical analysts, clinical pharmacologists,
clinical and forensic laboratories, and poison information centres. |
Contents:
Volume – I:
Part-I:
Chapters
1. Hospital Toxicology,
2. Therapeutic Drug Monitoring
3. Workplace Drug Testing
4. Driving Under the Influence of Alcohol
5. Driving Under the Influence of Drugs
6. Drug Testing in Human Sport
7. Drug Testing in Animal Sport
8. Drug-facilitated Sexual Assault
9. Forensic Toxicology
10. Postmortem Toxicology
11. Drugs of Abuse
12. Medicinal Products
13. Solid Dosage Form Identification
14. Volatile Substances
15. Natural Toxins
16. Pesticides
17. Metals and Anions
18. Drugs in Saliva
19. Hair Analysis
20. Method Development and Validation
21. Quality Control in the Pharmaceutical
Industry
22. Quality Control and Accreditation in the
Toxicology
23. Measuring and Reporting Uncertainty
24. Pharmacokinetics and Metabolism
25. Pharmacogenomics
26. Interpretation of Toxicology Data
27. Paediatric Toxicology
28. Sampling, Storage and Stability
29. Extraction
30. Colour Tests
31. Immunoassays
32. Ultraviolet, Visible and Fluorescene
Spectrophotometry
33. Infrared Spectroscopy
34. Near-infrared Spectroscopy
35. Raman Spectroscopy
36. Nuclear Magnetic Resonance Spectroscopy
37. Mass Spectrometry
38. Liquid Chromatography-Mass Spectrometry
39. Thin Layer Chromatography
40. Gas Chromatography
41. High Performance Liquid Chromatography
42. Capillary Electrophoresis
43. Atomic Absorption Spectroscopy,
Inductively Coupled Plasma-Mass Spectrometry and other Techniques for measuring
the Concentrations of Metals
44. Emerging Techniques
Volume – II
Part-III: Monographs
Part-IV: Indexes of Analytical Data |
About the Editors:
Professor
Anthony C. Moffat
is Emeritus Professor of pharmaceutical Analysis at The School of Pharmacy,
University of London, where he was previously Head of the Centre for
pharmaceutical Analysis. He was also Chief Scientist at the Royal
Pharmaceutical Society. He has over 350 publications as well as the
co-authorship of eight books.
Previously he worked
for the Forensic Science Service for 23 years as Research Co-ordinator
(Birmingham Laboratory), Resources Manager (Huntingdon Laboratory), Head of
Quality Management (HQ, London), Assistant Director (Huntingdon Laboratory),
and Head of the Drugs and Toxicology Division at the Home Office Central
Research Establishment, Aldermaston. He has also been a Superintendent
Pharmacist in a community pharmacy, Assistant Professor of Biochemistry, Baylor
College of Medicine, Houston, Texas, and Chief Pharmacists, St. Leonard’s
Hospital, London.
An active member of
many professional and learned societies, his fellowship include the Royal
Pharmaceutical Society, Royal Society of Chemistry, Forensic Science Society,
International, Pharmaceutical Federation and the American Association of
Pharmaceutical Scientists as well as the membership of the International
Association of Forensic Toxicologists.
Professor
M. David Osselton
started his forensic toxicology career in 1974 when he went to work with Dr.
Alan Curry at the Home Office Central Research Establishment, Aldermaston. He
gained casework experience as Senior Toxicologist working at the Home Office
Forensic Science laboratories in Nottingham and huntingdon before returning to
Aldermaston in 1984 to succeed Dr. Anthony Moffat as Head of Research in
Alcohol, Drugs and Toxicology. In 1991, he was appointed Head of Toxicology for
the Forensic Science Service. In 2007 Professor Osselton went to Bournemouth
University as Head of the Centre for Forensic Sciences. He has wide experience
in toxicology casework and has been involved in numerous high profile cases
working for the defence and prosecution both in the UK and overseas. He is
internationally known for his research interests in toxicology and lectures
widely at conferences as a plenary and keynote speaker. Between 2003 and 2009
he was Lead Assessor (Toxicology) for the UK Council for the Registration of
Forensic Practitioners (CRFP) and was Visiting Professor to the Department of
Forensic Science and Drug Monitoring at Kings College, University of London
(2004-2007). He is a fellow/Member of a number of professional and learned
bodies including the Royal Society of Chemistry, Royal Society of Medicine,
Expert Witness Institute, International Association of Forensic Toxicologists
(TIAFT), Society of Forensic Toxicologists (SOFT), LTG (formally the London
Toxicology Group), UK Workplace Drug testing Forum and is chair of the United
Kingdom and Ireland Association of Forensic Toxicologists.
Dr.
Brian Widdop
was Director of the Medical Toxicology Unit Laboratory at Guy’s Hospital,
London, from 1970 until 2002. Dr. Widdop has been a Speciality Assessor for the
Council for the Registration of Forensic Practitioners, a member of the WHO
IPCS Working Group on Analytical Toxicology, Chief Advisor to the South East
Asia Regional Office of the WHO on analytical toxicology and was a Director of
the Board of the UK Horse–racing Forensic Laboratory from 1991 to 2002. From
1997 to 2001, he was joint co-ordinator of the European proficiency Testing
Scheme for Drugs of Abuse. Dr. Widdop has published over 80 papers on various
aspects of clinical and analytical toxicology and has spoken at many
international meetings. He is also a member of the editorial board of the
journal of Analytical Toxicology.
Dr. Widdop belongs
to several international scientific societies and was a founder of the London
Toxicology Group. He has been a member of the International Association of
Forensic Toxicologists for 42 years and was the recipient of the Alan Curry
Award in 2002.
Dr. Jo Watts attained her degree in pharmacology and toxicology
followed by a PhD in neuropharmacology, both at The School of Pharmacy,
University of London. She is a member of TIAFT and the LTG. |